Trendlines sells ApiFix stake in its largest exit since IPO
Vivienne Tay
Singapore
CATALIST-LISTED startup incubator The Trendlines Group has sold its 18.62 per cent stake in ApiFix, a scoliosis treatment company, to Nasdaq-listed OrthoPediatrics.
This marks Trendlines' largest exit by value since its initial public offering in 2015. Its second-largest exit was ETView in 2016.